Primary Category:
Treatment Protocols
Disease Category:
Colon, Colon Metastatic, Gastrointestinal, Rectal, Rectal Metastatic
Status:
Temporarily Closed
A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (MCRC) with HER-2 Amplification
NCT#03365882
Effective immediately, May 17th, 2019, S1613 Step 1, is temporarily closed to accrual of new patients to accommodate the relocation of the screening laboratory. Patients may continue to be registered to Step 2.
